Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Cancer Research

• Publication date

  2011-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-10-2884PMID 21270110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

  2009cited by this paper
• Apoptosis and colorectal cancer: implications for therapy.

  2009influential reference
• Role of full-length osteoprotegerin in tumor cell biology

  2009cited by this paper
• What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?

  2008cited by this paper
• OPG Is Regulated by β-Catenin and Mediates Resistance to TRAIL-Induced Apoptosis in Colon Cancer

  2008cited by this paper
• Systemic treatment of colorectal cancer.

  2008cited by this paper
• Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function

  2008cited by this paper
• Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy

  2008cited by this paper
• A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies

  2008cited by this paper
• Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer

  2007cited by this paper
• Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US

  2007cited by this paper
• Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study.

  2007cited by this paper
• Role of osteoprotegerin (OPG) in cancer.

  2006cited by this paper
• The clinical trail of TRAIL.

  2006cited by this paper
• Osteoprotegerin (OPG)—a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?

  2006cited by this paper
• Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo – A Role in Tumour Cell Survival?

  2005cited by this paper
• Expression profiling by microarrays in colorectal cancer (Review).

  2005cited by this paper
• Osteoprotegerin is expressed in colon carcinoma cells.

  2005cited by this paper
• Mechanisms of resistance to TRAIL-induced apoptosis in cancer

  2005cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

  2004cited by this paper
• The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.

  2004cited by this paper
• Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

  2004cited by this paper
• Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.

  2003cited by this paper
• Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy

  2003cited by this paper
• Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

  2002cited by this paper
• Serum osteoprotegerin levels in healthy controls and cancer patients.

  2002cited by this paper
• Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development

  2002cited by this paper
• Osteoprotegerin and rank ligand expression in prostate cancer.

  2001cited by this paper
• Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles.

  2001cited by this paper
• Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*

  1998cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family*

  1996cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Colorectal cancer

  1993cited by this paper
• Cáncer

  1939cited by this paper

• Identification of GPD1L as a potential prognosis biomarker and associated with colorectal cancer progression

  2026cites this paper
• Targeting the NSUN2–DHODH axis reverses ferroptosis resistance and oxaliplatin resistance in colorectal cancer

  2026cites this paper
• Carnitine palmitoyltransferase 2 as a novel prognostic biomarker and immunoregulator in colorectal cancer.

  2025cites this paper
• m6A-induced DEAD-box RNA helicase 21 enhances lipid metabolism via 3‑hydroxy-3-methylglutaryl-CoA synthases 1 in colorectal cancer

  2025cites this paper
• Identification of EARS2 as a Potential Biomarker with Diagnostic, Prognostic, and Therapeutic Implications in Colorectal Cancer

  2025cites this paper
• A novel gene signature for predicting outcome in colorectal cancer patients based on tumor cell-endothelial cell interaction via single-cell sequencing and machine learning

  2025cites this paper
• M1 macrophages – unexpected contribution to tumor progression

  2025cites this paper
• Pan-Cancer Analyses of Shared and Distinct Gene Expression in 17 Cancers: Rethinking Cancer Classification and Moving Beyond “One Drug, One Disease” Paradigm of Pharmaceutical Innovation

  2025cites this paper
• Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers

  2025cites this paper
• Targeting KAT7 inhibits the progression of colorectal cancer

  2025cites this paper
• A computational approach reveals the critical role of PARK2 gene and the potential infectious pathways and HPV infection in colorectal cancer

  2025cites this paper
• Clonal dispersal is associated with tumor heterogeneity and poor prognosis in colorectal cancer

  2025cites this paper
• Genetic variants in VEGF gene family enhance colorectal cancer susceptibility via modulating metabolic pathways.

  2025cites this paper
• Regulatory role of phosphatidylcholine metabolic reprogramming in colorectal cancer progression and neutrophil interactions

  2025cites this paper
• SMAGS-LASSO: A Novel Feature Selection Method for Sensitivity Maximization in Early Cancer Detection.

  2025cites this paper
• Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling

  2024cites this paper
• Integrated Bioinformatics and Machine Learning Analysis Reveals Shared Key Candidate Biomarkers and Therapeutic Targets in Ulcerative Colitis and Colorectal Cancer

  2024cites this paper
• Integrating UPLC‐MS/MS Bioinformatics and In Vivo Experiments Validation to Elucidate the Mechanism of Wenzi Jiedu Decoction in Suppressing Colorectal Cancer

  2024cites this paper
• IFSWOA: Integrated Biomarker Selection Method Based on Incremental Feature Selection and Whale Optimization Algorithm

  2024cites this paper
• Identification and validation of Rab GTPases RAB13 as biomarkers for peritoneal metastasis and immune cell infiltration in colorectal cancer patients

  2024cites this paper
• SLC12A8 upregulation promotes colorectal cancer progression and chemoresistance

  2024cites this paper
• Discovery and validation of a 10-gene predictive signature for response to adjuvant chemotherapy in stage II and III colon cancer

  2024cites this paper
• Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis

  2024cites this paper
• DEPDC5 protects CD8+ T cells from ferroptosis by limiting mTORC1-mediated purine catabolism

  2024cites this paper
• Detecting phenotype-specific tumor microenvironment by merging bulk and single cell expression data to spatial transcriptomics

  2024cites this paper
• Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis

  2024cites this paper
• AEG-1 as a Novel Therapeutic Target in Colon Cancer: A Study from Silencing AEG-1 in BALB/c Mice to Large Data Analysis.

  2024cites this paper
• MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer

  2024influential citation
• Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub

  2024cites this paper
• Genetic variants in the calcium signaling pathway participate in the pathogenesis of colorectal cancer through the tumor microenvironment

  2023influential citation
• Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway

  2023cites this paper
• Weighted gene co-expression network analysis for hub genes in colorectal cancer

  2023cites this paper
• Downregulation of osteoprotegerin in colorectal cancer cells promotes liver metastasis via activating tumor-associated macrophage

  2023influential citation
• Investigating the Diagnostic and Therapeutic Potential of SREBF2-Related Lipid Metabolism Genes in Colon Cancer

  2023cites this paper
• Insights into the molecular mechanisms and signalling pathways of epithelial to mesenchymal transition (EMT) in colorectal cancer: A systematic review and bioinformatic analysis of gene expression.

  2023cites this paper
• Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study

  2023cites this paper
• USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis

  2023cites this paper
• Drug Repurposing Analysis for Colorectal Cancer through Network Medicine Framework: Novel Candidate Drugs and Small Molecules

  2023cites this paper
• Insilco prediction of the role of the FriZZled5 gene in colorectal cancer.

  2023cites this paper
• SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma

  2022cites this paper
• Transcriptome of Lung Cancer Cells Resistant to the Cytotoxic Activity of Macrophages

  2022cites this paper
• Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis

  2022cites this paper
• Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer

  2022cites this paper
• Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer

  2022influential citation
• SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition

  2022cites this paper
• Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis

  2022cites this paper
• Transcriptomic and Cellular Content Analysis of Colorectal Cancer by Combining Multiple Independent Cohorts

  2022cites this paper
• Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer

  2022cites this paper
• Motile sperm domain containing 1 is upregulated by the Wnt/β-catenin signaling pathway in colorectal cancer.

  2022cites this paper
• Dysadherin awakens mechanical forces and promotes colorectal cancer progression

  2022cites this paper
• Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker

  2022cites this paper
• A Three-Genes Signature Predicting Colorectal Cancer Relapse Reveals LEMD1 Promoting CRC Cells Migration by RhoA/ROCK1 Signaling Pathway

  2022cites this paper
• Modular and mechanistic changes across stages of colorectal cancer

  2022cites this paper
• Identification and functional validation of HLA-C as a potential gene involved in colorectal cancer in the Korean population

  2022cites this paper
• Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer

  2022cites this paper
• Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer

  2022cites this paper
• FOXQ1-mediated SIRT1 upregulation enhances stemness and radio-resistance of colorectal cancer cells and restores intestinal microbiota function by promoting β-catenin nuclear translocation

  2022influential citation
• Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway

  2022cites this paper
• DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer.

  2022cites this paper
• Analyzing large scale gene expression data in colorectal cancer reveals important clues; CLCA1 and SELENBP1 downregulated in CRC not in normal and not in adenoma.

  2022cites this paper
• TRIP13, identified as a hub gene of tumor progression, is the target of microRNA-4693-5p and a potential therapeutic target for colorectal cancer

  2022cites this paper
• DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.

  2022cites this paper
• High PHD Finger Protein 19 (PHF19) expression predicts poor prognosis in colorectal cancer: a retrospective study

  2021influential citation
• Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer

  2021cites this paper
• Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.

  2021cites this paper
• The lncRNA ZFAS1 regulates lipogenesis in colorectal cancer by binding polyadenylate-binding protein 2 to stabilize SREBP1 mRNA

  2021cites this paper
• PRMT5 promotes colorectal cancer growth by interaction with MCM7

  2021cites this paper
• Tribbles Gene Expression Profiles in Colorectal Cancer

  2021cites this paper
• SELENBP1 Inhibits Cell Proliferation and Migration in Colorectal Cancers by Suppressing EMT

  2021cites this paper
• Colon Cancer Progression Is Reflected to Monotonic Differentiation in Gene Expression and Pathway Deregulation Facilitating Stage–specific Drug Repurposing

  2021cites this paper
• Platelet-dependent signaling and Low Molecular Weight Protein Tyrosine Phosphatase expression promote aggressive phenotypic changes in gastrointestinal cancer cells.

  2021cites this paper
• Chronic Obstructive Pulmonary Disease and Its Acute Exacerbation before Colon Adenocarcinoma Treatment Are Associated with Higher Mortality: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study

  2021cites this paper
• Dysregulation of core circadian genes, BMAL1 and CLOCK, in colorectal cancer

  2021cites this paper
• Identification of the Effects of Chondroitin Sulfate on Inhibiting CDKs in Colorectal Cancer Based on Bioinformatic Analysis and Experimental Validation

  2021influential citation
• Aberrant expression of lncRNAs SNHG6, TRPM2‐AS1, MIR4435‐2HG, and hypomethylation of TRPM2‐AS1 promoter in colorectal cancer

  2021cites this paper
• Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A

  2021cites this paper
• A merged microarray meta-dataset for transcriptionally profiling colorectal neoplasm formation and progression

  2021cites this paper
• Increased Collagen Type V α2 (COL5A2) in Colorectal Cancer is Associated with Poor Prognosis and Tumor Progression

  2021cites this paper
• Long non-coding RNA AGAP2-AS1 is up regulated in colorectal cancer

  2021cites this paper
• Ordering of Omics Features Using Beta Distributions on Montecarlo p-Values

  2021cites this paper
• Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer

  2021cites this paper
• DAB2IP inhibits p53 ubiquitin-mediated degradation by competitively binding to GRP75 and suppresses tumor malignancy in colon cancer

  2021cites this paper
• Upregulated osteoprotegerin expression promotes lung cancer cell invasion by increasing miR-20a expression

  2021cites this paper
• Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer

  2021cites this paper
• A dynamic recursive feature elimination framework (dRFE) to further refine a set of OMIC biomarkers

  2021cites this paper
• MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer

  2021cites this paper
• lncRNA-miRNA-mRNA interaction network for colorectal cancer; An in silico analysis

  2020cites this paper
• Causal Disturbance Analysis: A Novel Graph Centrality Based Method for Pathway Enrichment Analysis

  2020cites this paper
• Correction: Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.

  2020cites this paper
• Comprehensive analysis reveals a four-gene signature in colorectal cancer

  2020influential citation
• Scoping for RNA biomarkers in colorectal cancer

  2020cites this paper
• Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer

  2020influential citation
• TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary

  2020influential citation
• Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics

  2020cites this paper
• Application of weighted gene co-expression network analysis to explore the potential diagnostic biomarkers for colorectal cancer

  2020cites this paper
• Construction and Analysis of a ceRNA Network Reveals Potential Prognostic Markers in Colorectal Cancer

  2020influential citation
• Identification of Key mRNAs and Pathways in Colorectal Cancer

  2020cites this paper
• P53-induced MRVI1 mediates carcinogenesis of colorectal cancer

  2020cites this paper
• Prognostic and Predictive Value of Cadherin 11 for Patients with Gastric Cancer and Its Correlation with Tumor Microenvironment: Results from Microarray Analysis

  2020influential citation
• B7-H3 is spliced by SRSF3 in colorectal cancer

  2020cites this paper